# Glucotrack, Inc. (GCTK) — merger/definitive [pending]
Source: sec.gov · situation sit_28ae92a310703fd3ad23 · public 9444181279991808011 · retrieved 2026-08-21T14:18:59.591Z

## Overview
We are a medical device company focused on the development of an implantable continuous blood glucose monitor ("CBGM") for persons with Type 1 diabetes and Type 2 diabetes using insulin or at risk for hypoglycemia (the "Glucotrack CBGM").

General Description of the Merger Agreement On July 14, 2026 (the " Closing Date "), Glucotrack, Inc., a Delaware corporation (the " Acquiror "), entered into an Agreement and Plan of Merger (the " Merger Agreement ") with Glucotrack Merger Sub, Inc., a Nevada corporation (" Merger Sub "), Lokahi Therapeutics, Inc., a Nevada corporation (the " Company "), Glucotrack Technologies Inc.

## Key dates
- Announced 2026-07-15

## Timeline
- 2026-07-15 · 425 (0001493152-26-033395): 425 - Glucotrack, Inc. — *We are a medical device company focused on the development of an implantable continuous blood glucose monitor ("CBGM") for persons with Type 1 diabetes and Type 2 diabetes using insulin or at risk for hypoglycemia (the "Glucotrack CBGM").* General Description of the Merger Agreement On July 14, 2026 (the " Closing Date "), Glucotrack, Inc., a Delaware corporation (the " Acquiror "), entered into an Agreement and Plan of Merger (the " Merger Agreement ") with Glucotrack Merger Sub, Inc., a Nevada corporation (" Merger Sub "), Lokahi Therapeutics, Inc., a Nevada corporation (the " Company "), Glucotrack Technologies Inc.
  https://www.sec.gov/Archives/edgar/data/1506983/0001493152-26-033395.txt

## Citations
- 0001493152-26-033395 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000149315226033395